Home › JDRF Translational Program Request for Tenders now open

JDRF Translational Program Request for Tenders now open

JDRF
JDRF
December 14, 2022

The JDRF Clinical Research Network (CRN) operates to fund world class type 1 diabetes (T1D) research in Australia with the highest likelihood of positively impacting the lives of the T1D community.

JDRF Australia is requesting tender submissions seeking technical expertise to support a Translational Program, an initiative of the CRN to accelerate early-stage scientific discoveries towards translation and commercialisation to improve lives for people living with type 1 diabetes.

Tenders are invited from parties external to JDRF with specialised expertise in assisting translation and commercialisation of investigator-led research.

Interested parties are highly encouraged to contact the JDRF team to discuss strategic fit and their proposed approach.

For more information on the goals and expected outcomes of this Program, and information on how to submit a Tender, please download the Terms of Reference.

Key Dates:

Submissions open 15th December 2022

Submission deadline 7th March 2023

How to apply:

Submissions must be emailed to crn@jdrf.org.au by 5pm on Tuesday 7th March 2023.

For enquires on strategic fit and submission requirements, please contact:

Auvro Mridha, PhD
Scientific Program Manager
JDRF Australia
E: amirdha@jdrf.org.au

Dorota Pawlak, PhD
Chief Scientific Officer
JDRF Australia
E: dpawlak@jdrf.org.au

 

Download the terms of reference
JDRF

Latest News

View all news
Australian researcher internationally recognised for achievements in type 1 diabetes screening
Australian researcher internationally recognised for achievements in type 1 diabetes screening

We are proud to announce that Dr Kirstine Bell from the Charles Perkins Centre at The University of Sydney has been awarded the 2023 JDRF Dr Robert Goldstein Award for her notable contributions to type 1 diabetes (T1D) research. This is an internationally competitive award given to early career researchers who show great promise in […]

Apr 18, 2024
Funding to characterise a new target for type 1 diabetes prevention
Funding to characterise a new target for type 1 diabetes prevention

JDRF is proud to announce new funding of $200,000 (USD) to Dr Irina Buckle from Mater Research and The University of Queensland, to undertake a project which aims to understand what may be driving type 1 diabetes.   Type 1 Diabetes (T1D) is a condition where certain types of immune cells, known as T cells, incorrectly […]

Apr 11, 2024
Sebastian’s Journey: Riding for awareness and change
Sebastian’s Journey: Riding for awareness and change

On Sunday 21 April 2024, a group of passionate cyclists are embarking on a wonderful fundraising initiative in memory of Sebastian Stafford, a cherished member of the type 1 diabetes (T1D) community.   Amateur cyclists from all areas of life will be taking on a 130km hard cycle from Bella Vista to the breathtaking Bowral to […]

Mar 28, 2024
New formulation of insulin may speed up its action for people with type 1 diabetes
New formulation of insulin may speed up its action for people with type 1 diabetes

A research group from Norway has found that adding small amounts of glucagon to insulin speeds up its action. For people with type 1 diabetes (T1D) this would mean a faster acting insulin than what is on the market, and in turn, improved quality of life.    The need for fast insulin T1D is an autoimmune […]

Mar 25, 2024